文献速递血管炎

GR基因单倍型与HSD11B1多态性对ANCA相关性血管炎临床结局的影响

Clinical outcome in anti-neutrophil cytoplasmic antibody-associated vasculitis and gene variants of 11β-hydroxysteroid dehydrogenase type 1 and the glucocorticoid receptor.
PubMed 文献 · Rheumatology (Oxford) · 2019-01-01

该研究对241例ANCA相关性血管炎患者进行GR基因5个多态性和HSD11B1基因1个多态性的基因分型,分析其与无复发生存、死亡率、肾脏生存、代谢不良事件及感染的关系。结果发现GR单倍型4携带者5年死亡风险和终末期肾病风险显著升高,HSD11B1次要变异携带者复发风险增加,GR单倍型1纯合携带者血脂异常风险升高,而感染在各基因型间无差异。

要点

  • GR单倍型4携带者5年死亡风险HR 4.5,终末期肾病风险HR 7.4。
  • HSD11B1次要变异携带者复发风险HR 2.5,但合并GR单倍型1时风险不增加。
  • GR单倍型1纯合携带者血脂异常风险HR 4.1,感染风险无差异。

核心结论

  • GR基因单倍型1和4及HSD11B1基因多态性与ANCA相关性血管炎的炎症和代谢结局相关。

研究设计与样本

  • 对241例诊断为ANCA相关性血管炎的患者进行GR基因5个多态性和HSD11B1基因1个多态性的基因分型,并预测GR单倍型。
  • 比较GR单倍型及HSD11B1基因型的携带者与非携带者之间无复发生存、死亡率、肾脏生存、代谢不良事件和感染的发生情况。

主要发现

  • GR单倍型4(ER22/23EK+9β+TthIII1)携带者5年死亡风险显著更高,HR 4.5(95%CI 1.6, 12.8)。
  • GR单倍型4携带者发生终末期肾病的风险更高,HR 7.4(95%CI 1.9, 28.7)。
  • HSD11B1次要变异携带者更频繁经历复发,HR 2.5(95%CI 1.5, 4.1),但若同时携带GR单倍型1(BclI)则不然。
  • GR单倍型1纯合携带者发生血脂异常的风险更高,HR 4.1(95%CI 1.8, 9.6)。
  • 感染的发生率在GR单倍型及HSD11B1基因型之间无差异。

临床怎么用

  • 对ANCA相关性血管炎患者,检测GR单倍型4和HSD11B1多态性可能有助于识别死亡、终末期肾病或复发高风险个体。
  • GR单倍型1纯合携带者需关注血脂异常风险,携带HSD11B1次要变异者需警惕复发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We aimed to investigate whether five potential functional haplotypes of the glucocorticoid receptor (GR) gene and a single-nucleotide polymorphism of 11β-hydroxysteroid dehydrogenase type 1 (HSD11B1) are associated with clinical outcome in ANCA-associated vasculitis. METHODS: Patients diagnosed with ANCA-associated vasculitis (n = 241) were genotyped for five polymorphisms of the GR gene and one polymorphism of the HSD11B1 gene. GR gene haplotypes were predicted based on genotyping results. Relapse-free survival, mortality, renal survival, metabolic adverse events and infections were compared between carriers and non-carriers of GR haplotypes and the HSD11B1 genotype. RESULTS: Carriers of haplotype 4 (ER22/23EK + 9β+TthIII1) of GR had a significantly higher 5-year mortality risk [hazard ratio (HR) 4.5 (95% CI 1.6, 12.8)] and had a higher risk of developing end-stage renal disease [HR 7.4 (95% CI 1.9, 28.7)]. Carriers of a minor variant of HSD11B1 more frequently experienced relapse [HR 2.5 (95% CI 1.5, 4.1)] except if they also carried haplotype 1 (BclI) of GR. Homozygous carriers of haplotype 1 had a higher risk of developing dyslipidaemia [HR 4.1 (95% CI 1.8, 9.6)]. The occurrence of infections did not differ between GR haplotypes and HSD11B1 genotypes. CONCLUSION: Haplotypes 1 and 4 of GR and a polymorphism of the HSD11B1 gene were associated with clinically relevant inflammatory and metabolic outcomes in ANCA-associated vasculitis.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Hessels AC, Tuin J, Sanders JSF, et al. Clinical outcome in anti-neutrophil cytoplasmic antibody-associated vasculitis and gene variants of 11β-hydroxysteroid dehydrogenase type 1 and the glucocorticoid receptor. Rheumatology (Oxford). 2019. PMID: 30445609. doi:10.1093/rheumatology/key319

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。